Inventor
OJALA ETHAN W
US46 patents
⚠️ This page may combine multiple inventors who share the name “OJALA ETHAN W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALDERBIO HOLDINGS LLC
24 patentsUS9085615B2Jul 21, 2015
Antibodies to IL-6 to inhibit or treat inflammation
ALDERBIO HOLDINGS LLC29 citations93
US9518082B2Dec 13, 2016
Antibody purification and purity monitoring
ALDERBIO HOLDINGS LLC16 citations91
US10533045B2Jan 14, 2020
Antibody purification and purity monitoring
ALDERBIO HOLDINGS LLC12 citations84
US9771421B2Sep 26, 2017
Treating anemia in chronic IL-6 associated diseases using anti-IL-6 antibodies
ALDERBIO HOLDINGS LLC5 citations84
US9725509B2Aug 8, 2017
Expression vectors containing isolated nucleic acids encoding anti-human IL-6 antibody
ALDERBIO HOLDINGS LLC9 citations84
US10844116B2Nov 24, 2020
Use of anti-pacap antibodies and antigen binding fragments thereof for treatment, prevention, or inhibition of photophobia
ALDERBIO HOLDINGS LLC3 citations83
US9834603B2Dec 5, 2017
Antibodies to IL-6 and use thereof
ALDERBIO HOLDINGS LLC7 citations83
US10913794B2Feb 9, 2021
Antibodies to IL-6 and use thereof
ALDERBIO HOLDINGS LLC2 citations73
US10800841B2Oct 13, 2020
Methods of treating autoimmunity using specific anti-IL-6 antibodies
ALDERBIO HOLDINGS LLC2 citations73
US10227402B2Mar 12, 2019
Anti-NGF antibodies and anti-NGF antibody fragments
ALDERBIO HOLDINGS LLC1 citations73
US9879074B2Jan 30, 2018
Antibodies to IL-6 and use thereof
ALDERBIO HOLDINGS LLC4 citations73
US9738713B2Aug 22, 2017
Methods of preventing or treating pain using anti-NGF antibodies
ALDERBIO HOLDINGS LLC1 citations63
US10759853B2Sep 1, 2020
Antibodies to IL-6 and use thereof
ALDERBIO HOLDINGS LLC0 citations52
US10457727B2Oct 29, 2019
Methods of preventing inflammation and treating pain using anti-NGF compositions
ALDERBIO HOLDINGS LLC0 citations52
US10344086B2Jul 9, 2019
Antibodies to IL-6 and use thereof
ALDERBIO HOLDINGS LLC0 citations52
US10233239B2Mar 19, 2019
Isolated host cells expressing anti-IL-6 antibodies
ALDERBIO HOLDINGS LLC0 citations52
US10221236B2Mar 5, 2019
Anti-NGF antibodies that selectively inhibit the association of NGF with TRKA without affecting the association of NGF with P75
ALDERBIO HOLDINGS LLC0 citations52
US9890214B2Feb 13, 2018
Antibodies to TNF α and use thereof
ALDERBIO HOLDINGS LLC0 citations52
US9718882B2Aug 1, 2017
Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with P75
ALDERBIO HOLDINGS LLC0 citations52
US9539324B2Jan 10, 2017
Methods of preventing inflammation and treating pain using anti-NGF compositions
ALDERBIO HOLDINGS LLC1 citations52
US9359432B2Jun 7, 2016
Methods of preventing or treating pain using anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75
ALDERBIO HOLDINGS LLC0 citations52
US9078878B2Jul 14, 2015
Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75
ALDERBIO HOLDINGS LLC0 citations52
US9067988B2Jun 30, 2015
Methods of preventing or treating pain using anti-NGF antibodies
ALDERBIO HOLDINGS LLC0 citations52
US9884909B2Feb 6, 2018
Anti-NGF compositions and use thereof
ALDERBIO HOLDINGS LLC1 citations50
H LUNDBECK AS
11 patentsUS11993648B2May 28, 2024
Screening method for identifying anti-PACAP antibodies or antibody fragments suitable for use in treating or preventing PACAP-associated photophobia or light aversion
H LUNDBECK AS3 citations85
US11938185B2Mar 26, 2024
Treatment of headache, migraine and/or photophobia conditions using humanized anti-PACAP antibodies
H LUNDBECK AS3 citations85
US10975135B2Apr 13, 2021
Humanized anti-PACAP antibodies
H LUNDBECK AS4 citations84
US10968268B2Apr 6, 2021
Humanized anti-PACAP antibodies
H LUNDBECK AS4 citations84
US10954285B2Mar 23, 2021
Humanized anti-PACAP antibodies
H LUNDBECK AS4 citations84
US12162936B2Dec 10, 2024
Methods of treatment with anti-PACAP antibodies
H LUNDBECK AS2 citations73
US11352409B2Jun 7, 2022
Anti-PACAP antibodies and uses thereof
H LUNDBECK AS2 citations73
US10981985B2Apr 20, 2021
Anti-PACAP antibodies
H LUNDBECK AS2 citations73
US12545725B2Feb 10, 2026
Anti-PACAP antibodies, nucleic acids and methods of making thereof
H LUNDBECK AS0 citations62
US12077581B2Sep 3, 2024
Anti-PACAP antibodies and uses thereof
H LUNDBECK AS0 citations62
US12590142B2Mar 31, 2026
Antibody purification and purity monitoring
H LUNDBECK AS0 citations61
ALDER BIOPHARMACEUTICALS INC
5 patentsUS10202435B2Feb 12, 2019
Anti-PACAP antibodies and uses thereof
ALDER BIOPHARMACEUTICALS INC9 citations92
US10913783B2Feb 9, 2021
Humanized anti-PACAP antibodies and uses thereof
ALDER BIOPHARMACEUTICALS INC4 citations83
US10981984B2Apr 20, 2021
Methods of determining whether anti-PACAP antibodies inhibit PACAP-associated photophobia or light aversion
ALDER BIOPHARMACEUTICALS INC3 citations82
US11254741B2Feb 22, 2022
Anti-PACAP antibodies
ALDER BIOPHARMACEUTICALS INC2 citations72
US10899834B2Jan 26, 2021
Anti-PACAP antibodies
ALDER BIOPHARMACEUTICALS INC2 citations72